Who owns CYCLERION THERAPEUTICS INC COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Cyclerion Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cyclerion Therapeutics stock

Who bought or sold CYCLERION THERAPEUTICS INC COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Kalehua Capital Management 1.7M $5.6M 100% Jun 2026
 View chart
FMR 650k $2.2M 13604% Jun 2026
 View chart
Balyasny Asset Management 318k $1.1M 100% Jun 2026
 View chart
ADAR1 Capital Management 299k $1.0M 100% Jun 2026
 View chart
Braidwell 157k $532k 100% Jun 2026
 View chart
Citadel Advisors 60k $203k 227% Jun 2026
 View chart
Geode Capital Management 46k $156k -46% Jun 2026
 View chart
Vanguard Capital Management 31k $105k 92% Jun 2026
 View chart
Rangeley Capital 24k $82k 100% Jun 2026
 View chart
Hrt Financial 22k $74k 100% Jun 2026
 View chart
BlackRock 17k $57k 0% Jun 2026
 View chart
Dimensional Fund Advisors 12k $40k 100% Jun 2026
 View chart
Vanguard Fiduciary Trust 7.4k $25k 0% Jun 2026
 View chart
UBS Group 3.1k $11k -8% Jun 2026
 View chart
Tower Research Capital 1.8k $6.3k 100% Jun 2026
 View chart
Group One Trading 192.00 $650.995200 0% Jun 2026
 View chart
Advisor Group Holdings 130.00 $439.998000 0% Jun 2026
 View chart
Activest Wealth Management 100.00 $339.000000 0% Jun 2026
 View chart
Citigroup 89.00 $136.997700 100% Mar 2026
 View chart
Barclays 87.00 $294.999600 100% Jun 2026
 View chart
Whi Trust 72.00 $244.000800 0% Jun 2026
 View chart
Bnp Paribas Arbitrage, Snc 4.00 $14.000000 -20% Jun 2026
 View chart
Morgan Stanley 1.00 $2.000000 0% Mar 2026
 View chart

Who sold out of Cyclerion Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Kovack Advisors Mar 2026 10k $16k
MAI Wealth Advisors Mar 2026 100.00 $155.000000
Caitong International Asset Management Mar 2026 4.00 $6.000000